389 related articles for article (PubMed ID: 10553708)
21. In vitro antibacterial activity and pharmacodynamics of new quinolones.
Dalhoff A; Schmitz FJ
Eur J Clin Microbiol Infect Dis; 2003 Apr; 22(4):203-21. PubMed ID: 12687416
[TBL] [Abstract][Full Text] [Related]
22. In vitro activity of DU-6859a against anaerobic bacteria.
Wexler HM; Molitoris E; Reeves D; Finegold SM
Antimicrob Agents Chemother; 1994 Oct; 38(10):2504-9. PubMed ID: 7840599
[TBL] [Abstract][Full Text] [Related]
23. Comparative in vitro activity of gemifloxacin.
King A; May J; French G; Phillips I
J Antimicrob Chemother; 2000 Apr; 45 Suppl 1():1-12. PubMed ID: 10824026
[TBL] [Abstract][Full Text] [Related]
24. The fluoroquinolone antibacterials: past, present and future perspectives.
Appelbaum PC; Hunter PA
Int J Antimicrob Agents; 2000 Sep; 16(1):5-15. PubMed ID: 11185413
[TBL] [Abstract][Full Text] [Related]
25. Comparison of in vitro activities of DU-6859a and other fluoroquinolones against Japanese isolates of anaerobic bacteria.
Kato N; Kato H; Tanaka-Bando K; Watanabe K; Ueno K
Clin Infect Dis; 1996 Dec; 23 Suppl 1():S31-5. PubMed ID: 8953104
[TBL] [Abstract][Full Text] [Related]
26. Expanded activity and utility of the new fluoroquinolones: a review.
Blondeau JM
Clin Ther; 1999 Jan; 21(1):3-40; discussion 1-2. PubMed ID: 10090423
[TBL] [Abstract][Full Text] [Related]
27. [The history of the development and changes of quinolone antibacterial agents].
Takahashi H; Hayakawa I; Akimoto T
Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
[TBL] [Abstract][Full Text] [Related]
28. Antibacterial activities of grepafloxacin, ciprofloxacin, ofloxacin and fleroxacin.
Barry AL; Fuchs PC
J Chemother; 1997 Feb; 9(1):9-16. PubMed ID: 9106012
[TBL] [Abstract][Full Text] [Related]
29. In vitro activity of enoxacin versus ciprofloxacin, fleroxacin, lomefloxacin, ofloxacin, pefloxacin, and rufloxacin against uropathogens.
Naber KG; Well M; Hollauer K; Kirchbauer D; Witte W
Chemotherapy; 1998; 44(2):77-84. PubMed ID: 9551236
[TBL] [Abstract][Full Text] [Related]
30. Activity of BMS284756 (T-3811) tested against anaerobic bacteria, Campylobacter jejuni, Helicobacter pylori and Legionella spp.
Rhomberg PR; Biedenbach DJ; Jones RN
Diagn Microbiol Infect Dis; 2001; 40(1-2):45-9. PubMed ID: 11448563
[TBL] [Abstract][Full Text] [Related]
31. Antibacterial properties of AM-1155, a new 8-methoxy quinolone.
Hosaka M; Kinoshita S; Toyama A; Otsuki M; Nishino T
J Antimicrob Chemother; 1995 Aug; 36(2):293-301. PubMed ID: 8522459
[TBL] [Abstract][Full Text] [Related]
32. Quinolones: clinical use and formulary considerations.
Cunha BA
Adv Ther; 1998; 15(5):277-87. PubMed ID: 10345149
[TBL] [Abstract][Full Text] [Related]
33. Patterns of susceptibility to fluoroquinolones among anaerobic bacterial isolates in the United States.
Goldstein EJ
Clin Infect Dis; 1993 Jun; 16 Suppl 4():S377-81. PubMed ID: 8324151
[TBL] [Abstract][Full Text] [Related]
34. Increased activity of a new chlorofluoroquinolone, BAY y 3118, compared with activities of ciprofloxacin, sparfloxacin, and other antimicrobial agents against anaerobic bacteria.
Aldridge KE
Antimicrob Agents Chemother; 1994 Jul; 38(7):1671-4. PubMed ID: 7979307
[TBL] [Abstract][Full Text] [Related]
35. Bactericidal activity of DU-6859a compared to activities of three quinolones, three beta-lactams, clindamycin, and metronidazole against anaerobes as determined by time-kill methodology.
Spangler SK; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1997 Apr; 41(4):847-9. PubMed ID: 9087503
[TBL] [Abstract][Full Text] [Related]
36. Correlation of in vitro activities of the fluoroquinolones to their in vivo efficacies.
Fernandes PB; Swanson RN
Drugs Exp Clin Res; 1988; 14(6):375-8. PubMed ID: 3145851
[TBL] [Abstract][Full Text] [Related]
37. In vitro antibacterial activity of DU-6859a, a new fluoroquinolone.
Nakane T; Iyobe S; Sato K; Mitsuhashi S
Antimicrob Agents Chemother; 1995 Dec; 39(12):2822-6. PubMed ID: 8593031
[TBL] [Abstract][Full Text] [Related]
38. Overview of the fluoroquinolone antibiotics.
Just PM
Pharmacotherapy; 1993; 13(2 Pt 2):4S-17S. PubMed ID: 8386356
[TBL] [Abstract][Full Text] [Related]
39. In vitro activity of Bay 12-8039, a new 8-methoxyquinolone, compared to the activities of 11 other oral antimicrobial agents against 390 aerobic and anaerobic bacteria isolated from human and animal bite wound skin and soft tissue infections in humans.
Goldstein EJ; Citron DM; Hudspeth M; Hunt Gerardo S; Merriam CV
Antimicrob Agents Chemother; 1997 Jul; 41(7):1552-7. PubMed ID: 9210683
[TBL] [Abstract][Full Text] [Related]
40. In vitro activities of irloxacin and E-3846, two new quinolones.
García-Rodríguez JA; García Sánchez JE; Muñoz Bellido JL; Trujillano I
Antimicrob Agents Chemother; 1990 Jun; 34(6):1262-7. PubMed ID: 2393288
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
